Twenty years on: what do we really know about Ewing sarcoma and what is the path forward?

E Lawlor, PH Sorensen - Critical Reviews™ in Oncogenesis, 2015 - dl.begellhouse.com
Ewing sarcoma (ES) is a highly aggressive bone and soft-tissue tumor with peak incidence
among adolescents and young adults. Despite advances in local control and systemic …

Two death-inducing human TRAIL receptors to target in cancer: similar or distinct regulation and function?

IAM van Roosmalen, WJ Quax, FAE Kruyt - Biochemical Pharmacology, 2014 - Elsevier
The emergence during evolution of two tumour necrosis factor (TNF)-related apoptosis-
inducing ligand (TRAIL) receptors, receptor-1/DR4 and-2/DR5, able to induce apoptosis has …

TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data

Z Gamie, K Kapriniotis, D Papanikolaou, E Haagensen… - Cancer letters, 2017 - Elsevier
Bone sarcomas are rare, highly malignant mesenchymal tumours that affect teenagers and
young adults, as well as older patients. Despite intensive, multimodal therapy, patients with …

Differential impacts of alternative splicing networks on apoptosis

JC Lin, MF Tsao, YJ Lin - International journal of molecular sciences, 2016 - mdpi.com
Apoptosis functions as a common mechanism to eliminate unnecessary or damaged cells
during cell renewal and tissue development in multicellular organisms. More than 200 …

The first European interdisciplinary Ewing sarcoma research summit

H Kovar, J Alonso, P Aman, DNT Aryee, J Ban… - Frontiers in …, 2012 - frontiersin.org
The European Network for Cancer Research in Children and Adolescents (ENCCA)
provides an interaction platform for stakeholders in research and care of children with …

Novel RANK antagonists for the treatment of bone‐resorptive disease: theoretical predictions and experimental validation

S Téletchéa, V Stresing, S Hervouet… - Journal of Bone and …, 2014 - academic.oup.com
Receptor activator of nuclear factor‐κB (RANK) and RANK ligand (RANKL) play a pivotal
role in bone metabolism, and selective targeting of RANK signaling has become a promising …

[HTML][HTML] Efficacy of ONC201 in desmoplastic small round cell tumor

AA Hayes-Jordan, X Ma, BA Menegaz… - Neoplasia, 2018 - Elsevier
Abstract Desmoplastic Small Round Cell Tumor (DSRCT) is a rare sarcoma tumor of
adolescence and young adulthood, which harbors a recurrent chromosomal translocation …

TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment

R Brion, M Gantier, K Biteau, J Taurelle… - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcoma and Ewing sarcoma are the two most common malignant
primary bone tumors occurring during childhood. These highly aggressive cancers are still …

TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer

L Danish, D Stöhr, P Scheurich, N Pollak - … , Fas ligand, TNF and TLR3 in …, 2017 - Springer
The tumour necrosis factor (TNF) ligand family member TNF-related apoptosis-inducing
ligand (TRAIL) induces apoptosis predominantly in tumour cells, but not in normal tissues …

Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma

Z Kang, SD Goldstein, Y Yu, PS Meltzer… - British journal of …, 2015 - nature.com
Background: Despite good initial response to chemotherapy, 30% of Ewing's sarcoma
(EWS) patients with localised tumours develop recurrent disease, associated with poor …